For early prostate cancer, 'active surveillance' is now the number 1 choice

Дата публикации: 13-08-2026 15:00:04

Three decades after UC San Francisco pioneered "active surveillance" for patients with low-risk prostate cancer, a new study has found that the vast majority of veterans with the diagnosis pursued this option instead of treatment.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Half of prostate cancer focal therapy use found to fall outside current guideline-supported groups	0	7.2	13-08-2026
2	New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies	5	7	18-04-2024
3	Researchers develop mathematical measures to better personalize therapy for prostate cancer	0	7.4	13-08-2026
4	Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer	0	8	09-07-2024
5	Prostatakrebs: Beobachten bei niedrigem Risiko	0	10	06-08-2026
6	Promising new options for treating aggressive prostate cancer	7	8	18-10-2023
7	“Prostate cancer is asymptomatic; in Malaga we detect 1,200 cases a year”	0	9.26	01-07-2026
8	Malaga doctor warns of nighttime prostate cancer symptom and highlights 'radioactive missile' treatment	0	7.97	11-06-2026
9	Prostate cancer treatment given to thousands of UK men piles on the pounds and increases risk of heart problems, study finds	0	5.63	13-08-2026
10	ASTRO updates guideline on radiation therapy for pancreatic cancer	0	7.3	13-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.98. Источник: medicalxpress.com.